Consistently, IHC staining of xenograft tumor tissues using TGF-β, BMP4, ICAM1 and VCAM1 antibodies indicated suppression of the TGF-β signaling pathway status in PGAM1 silencing cancer cells compared to that in the control group (Fig. 5h). This evidence concerns the gene PGAM1 and cancer.